Serum eosinophil chemotactic factor levels in patients with bullous pemphigoid, drug reactions and atopic eczema.
The sera of 4 patients with bullous pemphigoid, of 5 patients with drug reactions and of 13 patients with atopic eczema were examined for the occurrence of low molecular weight eosinophil chemotactic factor (ECF) by fractionation on a Sephadex G 25 column. Almost all patients had a peripheral eosinophilia, and many had raised total serum IgE levels. ECF was demonstrated in the sera of all 4 patients with bullous pemphigoid and in 4 of 5 patients with systemic drug reactions. In contrast, the sera of the 13 patients with atopic eczema did not contain any ECF activity, nor did the 13 control sera. These findings suggest that the ECF from phagocytosing polymorphonuclear leukocytes (PMN) and/or the mast cell derived ECF-A contribute to the elevated serum ECF levels in patients with bullous pemphigoid and drug reactions. A correlation between serum ECF and IgE levels and peripheral eosinophilia could not be established.
D002634:Chemotaxis, Leukocyte; D002648:Child; D003875:Drug Eruptions / Q000097:blood* / Q000150:complications; D004485:Eczema / Q000097:blood* / Q000150:complications; D004802:Eosinophilia / Q000209:etiology; D004804:Eosinophils / Q000378:metabolism*; D006801:Humans; D007073:Immunoglobulin E / Q000378:metabolism; D012872:Skin Diseases, Vesiculobullous / Q000097:blood* / Q000150:complications
D007073:Immunoglobulin E